Literature DB >> 15270587

The male lumpectomy: rationale for a cancer targeted approach for prostate cryoablation. A review.

Gary Onik1.   

Abstract

Lumpectomy to treat breast cancer has revolutionized the management of that disease. Lumpectomy showed that the quality of life of the individual patient can successfully be integrated into the equation of cancer treatment, without major loss of cancer treatment efficacy. Prostate cancer raises many of the same issues that breast cancer does in women. Impotence and incontinence, affects the male self image and psyche no less than the loss of a breast does a woman. Management of prostate cancer ranges from no treatment at all ("watchful waiting") to treatments in which the whole gland is destroyed (radiation therapy, cryosurgery) or removed (radical prostatectomy), with presently no treatment in between these extremes. Pathologic literature indicates, however, that 35% of prostate cancers are solitary and unilateral. In addition, long term studies have confirmed that cryoabltion for prostate cancer is an efficacious treatment. In this paper we will examine the rationale for a "male lumpectomy" using cryoablation and present preliminary data supporting it's role in prostate cancer management.

Entities:  

Mesh:

Year:  2004        PMID: 15270587     DOI: 10.1177/153303460400300406

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  13 in total

1.  MRI of frozen tissue demonstrates a phase shift.

Authors:  Aiming Lu; Bruce L Daniel; Elena Kaye; Kim Butts Pauly
Journal:  Magn Reson Med       Date:  2011-05-31       Impact factor: 4.668

Review 2.  Contemporary outcomes of focal therapy in prostate cancer: what do we know so far...

Authors:  John F Ward
Journal:  World J Urol       Date:  2010-08-03       Impact factor: 4.226

Review 3.  Image guidance in the focal treatment of prostate cancer.

Authors:  Anthony N Hoang; Dmitry Volkin; Nitin K Yerram; Srinivas Vourganti; Jeffrey Nix; W Marston Linehan; Bradford Wood; Peter A Pinto
Journal:  Curr Opin Urol       Date:  2012-07       Impact factor: 2.309

Review 4.  Cryotherapy.

Authors:  Katsuto Shinohara
Journal:  Int J Clin Oncol       Date:  2007-12-21       Impact factor: 3.402

Review 5.  Photodynamic therapy for prostate cancer--a review of current status and future promise.

Authors:  Caroline M Moore; Doug Pendse; Mark Emberton
Journal:  Nat Clin Pract Urol       Date:  2009-01

Review 6.  Focal therapy in prostate cancer: modalities, findings and future considerations.

Authors:  Uri Lindner; John Trachtenberg; Nathan Lawrentschuk
Journal:  Nat Rev Urol       Date:  2010-09-14       Impact factor: 14.432

Review 7.  Mechanisms of cryoablation: clinical consequences on malignant tumors.

Authors:  J G Baust; A A Gage; T E Bjerklund Johansen; J M Baust
Journal:  Cryobiology       Date:  2013-11-13       Impact factor: 2.487

8.  Residual tumor potentially left behind after local ablation therapy in prostate adenocarcinoma.

Authors:  Ghil Suk Yoon; Wenle Wang; Adeboye O Osunkoya; Zhaoli Lane; Alan W Partin; Jonathan I Epstein
Journal:  J Urol       Date:  2008-04-18       Impact factor: 7.450

Review 9.  Multiparametric magnetic resonance imaging in the management and diagnosis of prostate cancer: current applications and strategies.

Authors:  Daniel J Lee; Hashim U Ahmed; Caroline M Moore; Mark Emberton; Behfar Ehdaie
Journal:  Curr Urol Rep       Date:  2014-03       Impact factor: 3.092

Review 10.  Focal or subtotal therapy for early stage prostate cancer.

Authors:  J Stephen Jones
Journal:  Curr Treat Options Oncol       Date:  2007-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.